| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/25/2009 | CN101391105A Gene therapy for critical limb ischemia with wild type or mutant eNOS |
| 03/25/2009 | CN101391099A Use of growth hormone releasing peptides sustained release preparation in promoting fur-bearing animal grow |
| 03/25/2009 | CN101391001A Traditional Chinese medicine composition for preventing altitude stress and preparation method thereof |
| 03/25/2009 | CN101390875A New use of organic salt and inorganic salt composite solution |
| 03/25/2009 | CN101390855A New method for preparing solution for skin test |
| 03/25/2009 | CN101390852A Melanogenesis inhibitor and skin preparation containing the same |
| 03/25/2009 | CN100471853C Phenyl-thiophene type vitamin D receptor modulators |
| 03/25/2009 | CN100471850C Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidative activity |
| 03/25/2009 | CN100471522C Polynucleotide compsn. method of prepn. and use thereof |
| 03/25/2009 | CN100471502C Composition for cell proliferation |
| 03/25/2009 | CN100471492C Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 03/25/2009 | CN100471488C Chinese medicine composition for transquilizing, warming Yang, benefiting Qi and nourishing heart and its prepn |
| 03/24/2009 | US7507841 Cannabinoid receptor modulator |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507759 Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione |
| 03/24/2009 | US7507753 Biaryl compound and use thereof |
| 03/24/2009 | US7507750 e.g. L-Ascorbic acid-2-phosphoric acid-6-(2'-hexyldecanoate) sodium salt; collagen production accelerators; skin whitening; medical, pharmaceutical preparations, feeds, foods and agrochemicals; storage stability, |
| 03/24/2009 | US7507744 Spiroazabicyclic heterocyclic compounds |
| 03/24/2009 | US7507741 Heterocyclic compounds |
| 03/24/2009 | US7507740 Fused heterocyclic compound |
| 03/24/2009 | US7507725 Compounds with sulphonamide group and pharmaceutical compositions containing these compounds |
| 03/24/2009 | US7507723 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 03/24/2009 | US7507720 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 03/24/2009 | US7507707 phosphodiesterase inhibitor; follicle stimulating hormone; clomiphene; anovulation disorder; collecting oocytes for in vitro fertilization; aromatase inhibitor |
| 03/24/2009 | US7507705 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 03/24/2009 | US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507407 Immunoliposomes that optimize internationalization into target cells |
| 03/24/2009 | US7507398 Using condensation aerosol (MMAD of less than 5 microns) formed by vaporizing a thin layer of the drug on a solid support and condensing the vapor to treat anxiety, vertigo, alcohol or nicotine withdrawal, sedation, hot flashes, peptic ulcers or for hormone replacement therapy, or pregnancy prevention |
| 03/24/2009 | US7507397 Delivery of muscle relaxants through an inhalation route |
| 03/24/2009 | CA2431100C Dihydroindole and tetrahydroquinoline derivatives |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2407894C Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 03/24/2009 | CA2382404C Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/24/2009 | CA2345896C A method of modulating ion channel functional activity |
| 03/24/2009 | CA2336628C Method for reducing the damaging effects of radiation therapy on animal skin and mucosa |
| 03/24/2009 | CA2320717C Method for the treatment of diseases or disorders of the inner ear |
| 03/24/2009 | CA2224060C Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 03/24/2009 | CA2176373C Farnesyl derivatives and pharmaceutical compositions containing them |
| 03/24/2009 | CA2136969C Prevention and treatment of peripheral neuropathy |
| 03/19/2009 | WO2009035157A1 Therapeutic and/or prophylactic agent for lower urinary tract symptoms after radiotherapy |
| 03/19/2009 | WO2009035068A1 Novel 1,3,3-trimethyl-7-phenyl-3,4-dihydro-1h-quinoxalin- 2-one derivatives |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009035055A1 Insulin-like growth factor-1 (igf-1) production promoter |
| 03/19/2009 | WO2009035020A1 Novel dihydronaphthalene compound and use thereof |
| 03/19/2009 | WO2009034976A1 Alkylsulfone derivative |
| 03/19/2009 | WO2009033768A2 Use of a peptide as a therapeutic agent |
| 03/19/2009 | WO2009033767A2 Use of a peptide as a therapeutic agent |
| 03/19/2009 | WO2009014637A3 Heterocyclic amide compounds as protein kinase inhibitors |
| 03/19/2009 | WO2009000296A3 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 03/19/2009 | US20090076276 such as (R)-3-(3-hydroxypyrrolidin-1-yl)-N-methyl-N-methoxypropanamide; poly(ADP-ribose)polymerase inhibitors |
| 03/19/2009 | US20090076257 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090076168 Amine-based and imine-based polymers, uses and preparation thereof |
| 03/19/2009 | US20090076157 Deuterium-enriched senicapoc |
| 03/19/2009 | US20090076110 An amine salt of nitric acid and aginine, beta alanine, agmatine, citrulline, creatine, glutamine, L-histidine, isoleucine, leucine,norvaline, or ornithine; vasodilation; metabolism of mucle protein;exercise |
| 03/19/2009 | US20090076073 Therapeutic amides |
| 03/19/2009 | US20090076024 Episomal Fusion Gene |
| 03/19/2009 | US20090076023 Local Anesthetic Methods and Kits |
| 03/19/2009 | US20090076003 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 03/19/2009 | US20090075973 Benzo-fused heterocycles |
| 03/19/2009 | US20090075964 Fragrance compositions and other compositions which contain naturally occurring substances found in corals |
| 03/19/2009 | US20090075911 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090075908 Agent For Strengthening Calcium Containing Tissue and Use Thereof |
| 03/19/2009 | US20090075901 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/19/2009 | US20090075889 Iren protein, its preparation and use |
| 03/19/2009 | US20090075882 Receptor-mediated uptake of an extracellular bcl-xl fusion protein inhibits apoptosis |
| 03/19/2009 | US20090075873 Gastrin compositions and formulations, and methods of use and preparation |
| 03/19/2009 | US20090075864 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 03/19/2009 | US20090075863 Periosteal Tissue Grafts |
| 03/19/2009 | US20090075373 Neural progenitor cells derived from embryonic stem cells |
| 03/19/2009 | US20090075302 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075279 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075278 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090074859 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 03/19/2009 | US20090074851 Cpg-packaged liposomes |
| 03/19/2009 | US20090074848 Combination formulations of cytidine analogs and platinum agents |
| 03/19/2009 | US20090074794 for use in the treatment of crohn's and ulcerative colitis; administering a composition comprising an effective amount of at least one isolated mammalian anti-tumor necrosis factor (TNF) antibody comprising at least one variable region comprising SEQ ID NO:7 and 8 |
| 03/19/2009 | US20090074770 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof |
| 03/19/2009 | US20090074756 Use of llt1 and/or cd161 for modulatting the activity of cells of the immune system |
| 03/19/2009 | US20090074733 Thymidylate kinase mutants and uses thereof |
| 03/19/2009 | US20090074729 Augmentation and repair of spincter defects with cells including fibroblasts |
| 03/19/2009 | US20090074727 Method of treating solid tumor |
| 03/19/2009 | US20090074726 Mva expressing modified hiv envelope, gag, and pol genes |
| 03/19/2009 | US20090074722 Products and methods for treating PTP lar diseases |
| 03/19/2009 | US20090074667 Diagnostic methods for the detection of risk of neurodevelopmental disorders |
| 03/19/2009 | CA2699167A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698371A1 Alkylsulfone derivatives |
| 03/18/2009 | EP2036924A2 Gene regulatory peptides |
| 03/18/2009 | EP2036916A1 Composition for promoting the production of equol |
| 03/18/2009 | EP2036903A1 Potentiator of radiation therapy |
| 03/18/2009 | EP2036902A2 Urea compounds active as vanilloid receptor antagonist for the treatment of pain |
| 03/18/2009 | EP2036894A1 Aurora inhibitor |
| 03/18/2009 | EP2036893A1 Abl KINASE INHIBITOR |
| 03/18/2009 | EP2036891A2 Isoquinoline inhibitors of P38 |
| 03/18/2009 | EP2036887A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 03/18/2009 | EP2036565A1 Preparation for external application to skin containing triterpenic acid |
| 03/18/2009 | EP2036564A1 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 03/18/2009 | EP2036560A1 (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy |
| 03/18/2009 | EP2036552A1 Senescence inhibitor |